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Background: Epidemiological studies have shown that the offspring of mothers who experience diabetes mellitus
during pregnancy are seven times more likely to develop health complications than the offspring of mothers who
do not suffer from diabetes during pregnancy. The present study was designed to investigate whether
supplementation of streptozotocin (STZ)-induced diabetic pregnant mice with thymoquinone (TQ) during
pregnancy and lactation improves the risk of developing diabetic complications acquired by their offspring.
Methods: Three groups of pregnant female mice were used: non-diabetic control dams (CD), diabetic dams (DD), and
diabetic dams supplemented with TQ (DD + TQ) during pregnancy and lactation (n = 10 female mice in each group).
Results: Our data demonstrated a marked decrease in the number of neonates born to DD, and these neonates
showed a marked increase in their mean body weight (macrosomic pups) compared to those born to CD and DD +
TQ. The induction of diabetes during pregnancy and lactation resulted in macrosomic pups with several postpartum
complications, such as a marked increase in their levels of blood glucose, free radicals, plasma pro-inflammatory
cytokines (IL-1β, IL-6, and TNF-α), and lipids, and a tendency toward abnormal obesity compared to the offspring of CD.
By contrast, macrosomic offspring born to DD exhibited a marked reduction in plasma cytokine levels (IL-2, -4 and -7),
an obvious reduction in the number of circulating lymphocytes, decreased proliferation of superantigen (SEB)-
stimulated lymphocytes and aberrant AKT phosphorylation. Interestingly, the supplementation of DD with TQ during
pregnancy and lactation had an obvious and significant effect on the number and mean body weight of neonates.
Furthermore, TQ significantly restored the levels of blood glucose, insulin, free radicals, plasma cytokines, and lipids as
well as lymphocyte proliferation in the offspring.
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Conclusions: Our data suggest that the nutritional supplementation of DD with the natural antioxidant TQ during
pregnancy and lactation protects their offspring from developing diabetic complications and preserves an efficient
lymphocyte immune response later in life.
Keywords: Maternal diabetes, Offspring, Obesity, T cell immune response, PI3K/AKT signalingBackground
Gestational diabetes mellitus (GDM) is defined as diabetes
with initial onset during pregnancy [1]. Maternal hypergly-
cemia gives rise to complications for both the mother and
child. These complications include macrosomia, problems
with delivery that are usually associated with fetal
overgrowth, and increased rates of caesarean section [2].
Furthermore, obesity appears to be another long-term
complication in offspring born to mothers with GDM [3].
In particular, a recent rat study revealed that the offspring
of diabetic dams exhibited abnormal changes in their lipid
profile as well as metabolic disorders that can affect the
growth and metabolism of their descendants and subse-
quent generations [4]. In addition, the offspring of women
with diabetes during pregnancy are at increased risk of
developing hypertension and other cardiovascular diseases
[5]. Insulin resistance and insulin secretion, the metabolic
predictors of diabetes development, have been investigated
in the offspring of diabetic mothers in humans and animal
models [6]. Because insulin from the mother does not
cross the placenta, the pancreatic insulin output of the
fetus is solely determined by the glucose levels in the
maternal blood [7]. Evidence suggests that prenatal expo-
sure to a diabetic intrauterine environment is associated
with increased risk for impaired glucose tolerance [8] and
type 2 diabetes among offspring [9]. The involvement of
oxidative stress is one of the earliest abnormalities
observed in diabetic subjects [10]. Moreover, fetuses from
mothers with gestational diabetes are at increased risk of
developing oxidative stress, which subsequently induces
the production of highly reactive oxygen radicals, which
are toxic to cells, particularly to the plasma membrane,
where these radicals interact with the lipid bilayer [11]. In
humans it has been shown that when compared with non-
diabetic women, women with GDM exhibit a decreased
concentration of adiponectin (an anti-inflammatory agent)
and an increased concentration of TNF-α and IL-6 (pro-
inflammatory cytokines) [12]. By contrast, serum IL-4
levels do not differ between gestational diabetic mothers
and control mothers or macrosomic babies and control
babies [13]. High levels of pro-inflammatory cytokines
have also been implicated as major mediators of demyeli-
nation in the central nervous system, resulting in a variety
of inflammatory and neoplastic diseases, and many other
pathological complications [14]. By contrast, a decrease in
the plasma levels of IL-2 and IL-7 (T cell growth factorsthat promote T cell survival) occurs in several diseases and
reflects defective T cell function [15]. In addition, recent
studies have indicated that GDM mothers and their
newborns have lymphocyte subset impairments, which are
more important in patients who are positive for autoanti-
bodies and/or treated with insulin [16]. We previously
demonstrated in an animal model that neonates born
to diabetic dams exhibit a marked reduction in the
proliferative capacity of superantigen (SEB)-stimulated
T-lymphocytes and an obvious reduction in the number
of circulating and thymus homing T cells [17].
The beneficial effects of antioxidant supplementation
are attributed to the ability of these molecules to scavenge
free radicals, control nitric oxide synthesis or release,
inhibit reactive oxygen species generation, and upregulate
the activity of the antioxidant enzymes that metabolize
these molecules [18]. Plant-based antioxidants, such as
black seeds, have recently gained popularity due to their
role as dietary supplements that have minimal side effects.
Thymoquinone (TQ) is the major component of the
essential oil of black seeds and the biologically active
ingredient [19]. TQ has been reported to exhibit many
pharmacological effects, including immunomodulatory
[20], anticancer [21], anti-‐diabetic [22], antioxidant, and
anti-‐inflammatory [23] activities. TQ regulates the plasma
concentrations of cholesterol, triglycerides, and glu-
cose [19]. Despite studies that have demonstrated
strong evidence for the antioxidative effects of diffe-
rent natural products, there remains insufficient
information concerning the effects of TQ on develo-
ping diabetic complications and, in particular, on the
T cell immune response in GDM. Therefore, the
present study was designed to investigate whether
supplementation with TQ during pregnancy and lactation
periods to streptozotocin (STZ)-induced diabetic pregnant




STZ was obtained from Sigma Chemicals Co. (St.
Louis, MO, USA). STZ was dissolved in cold 0.01 M
citrate buffer (pH 4.5) and was always prepared
freshly for immediate use within 5 min. TQ was
obtained from Sigma Chemical Company (St Louis,
MO, USA).
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A total of 60 laboratory-bred Swiss albino mice of either
sex, 6-8 weeks of age and weighing 25-30 g were obtained
from the Faculty of Medicine of Assiut University (Assiut,
Egypt). All animal procedures were in accordance with the
standards of the National Institutes of Health (NIH).
The study protocol was approved by the Animal
Ethical Committee of Assiut University. The animals
were allowed to acclimatize for 2 weeks before the
experiment. The animals were housed in metal cages
inside a well-ventilated room. Each cage contained no
more than 2 mice (2 males or 2 females). The mice were
maintained under standard laboratory conditions: a
temperature of 25°C, a relative humidity of 60-70%, and a
12-hour light/dark cycle. The mice were fed a standard
commercial pellet diet and water.
All female mice were fasted for 20 h before diabetes
was induced with STZ. Mice (n = 30) were given 5
consecutive daily i.p. injections of STZ (50 mg/kg body
weight) in 0.1 M citrate buffer (pH 4.5) before mating
began. The animals were assigned to one of 2 experi-
mental groups (15 mice per group): one group received
only STZ, while the other received STZ and was orally
supplemented with TQ (20 mg/kg body weight/day)
during gestation and lactation. A control naive group
(n = 15) was injected with vehicle alone (0.1 M citrate
buffer [pH 4.5]) and orally supplemented with distilled
water (150 μl/mouse/day) during gestation and lactation.
After mating, the first day of gestation was determined
by the presence of spermatozoids in the vaginal smears.
Pregnant mice were housed individually in metal cages
under the above-mentioned conditions. To assess hyper-
glycemia during gestation, the tip of the tail was cut off,
and the tail was squeezed gently to collect blood. Blood
glucose levels were measured once per week after over-
night fasting, beginning with the day of the STZ injection
until 2 weeks postpartum using an AccuTrend sensor
(Roche Biochemicals, Mannheim, Germany). The data
were used to calculate the mean blood glucose levels for
each group, and mice were considered diabetic if glycemia
was higher than 220 mg/dl. The neonates were h.
Blood analysis
At the end of the experiment, the 8-week-old offspring
in each group were anesthetized with pentobarbital
(60 mg/kg body weight), the abdominal cavity was
opened, and whole blood was drawn from the abdominal
aorta. Plasma was obtained by low-speed centrifugation
(1,000 × g for 20 min) and immediately stored at -
80°C for subsequent cytokine profile analysis. PBMCs
were also isolated using the Ficoll gradient method.
Insulin levels were analyzed by Luminex (Biotrend,
Düsseldorf, Germany) according to the manufacturer’s
instructions.Measurement of free radical levels
The levels of reactive oxygen species (ROS) were deter-
mined using 2,7-dichlorodihydrofluorescein diacetate
(H2DCF-DA) (Beyotime Institute of Biotechnology,
Haimen, China). Hydroperoxide levels were evaluated
using a free radical analytical system (FRAS 2, Iram,
Parma, Italy). This test is a colorimetric test that takes
advantage of the ability of hydroperoxide to generate
free radicals after reaction with transition metals.
Lipid profile analysis
Lipid profiles were determined using BioMerieux kits and a
standard assay method. Cholesterol levels were evaluated
using the cholesterol esterase method. Triglycerides were
measured using the lipase method. HDL, LDL, and chylo-
microns were precipitated with phosphotungstic acid. The
amount of cholesterol bound to HDL was determined using
the cholesterol oxidase method and the phosphotungstate-
magnesium salt method using a Cholesterol E-Test Kit
(Wako, Osaka, Japan) as previously described [24].
Determination of plasma cytokine levels
Cytokine levels were determined in samples that were
stored at -80 C. Plasma cytokine (IL-1β, IL-2, IL-4, IL-6,
IL-7, and TNF-α) levels were determined by ELISA using
a Bio-Plex mouse cytokine assay kit (Bio-Rad, Hercules,
CA, USA) according to the manufacturer’s instructions.
CFSE proliferation assay
Peripheral blood mononuclear cells (PBMCs) were
isolated from blood using the Ficoll gradient method. The
PBMCs were then re-suspended at 20 × 106 cells/ml in 1X
phosphate buffered saline (PBS) and stained with 0.63 μM
carboxyfluorescein diacetate succinimidyl ester (CFSE)
(Molecular Probes, Eugene, OR, USA) for 8 min at
room temperature. The reaction was stopped with
FBS, and the cells were washed 3 times in PBS and
resuspended at 2 × 106 cells/ml in prewarmed R-10
medium. The CFSE-labeled cells were stimulated for
6 days with or without Staphylococcal enterotoxin B
(SEB) (final concentration of 5 ng/ml) at 37°C and 5%
CO2. On day 6, lymphocyte proliferation was analyzed
by flow cytometry.
Western blot analysis
Isolated PBMCs were pretreated with medium, wort-
mannin (WM; inhibitor of PI3K), and SH5 (inhibitor of
AKT phosphorylation) for 1 h before stimulation with or
without CXCL12 (250 ng/ml) for 5 min. Whole-cell
lysates were prepared from the PBMCs in RIPA buffer
(20 mM Tris-HCl [pH 7.5], 120 mM NaCl, 1.0% Triton
X-100, 0.1% SDS, 1% sodium deoxycholate, 10% glycerol,
1 mM EDTA, and 1% protease inhibitor cocktail [Roche]).
Following centrifugation at 16,000 × g for 15 min at 4°C,
Table 1 TQ supplementation improves materno-fetal parameters and neonatal outcome of pregnant diabetic dams
Control dams Diabetic dams Diabetic dams supplemented with TQ
Parameters
Total pregnancies 15 13 14
Successful pregnancies 14 9 12
Abortion (%) 6.66 31 14
Total neonates 121 64 96
Alive pups at four weeks 115 48 85
Dead pups 6 16 11
Mortality (%) 4.96 25 11.46
Blood glucose
(mg/dl)
Before pregnancy 3d after vehicle or STZ injection 178 ± 14.5 265 ± 19.7* 259 ± 17.4+
During pregnancy
1st W 193 ± 17.1 283 ± 21* 247 ± 23#+
2nd W 203 ± 18.7 311 ± 23.5* 257 ± 16.9#+
3rd W 187 ± 12.4 342 ± 28* 266 ± 23.5#+
After pregnancy 7d postpartum 179 ± 12.5 295 ± 28.4* 246 ± 19.3#+
The results are expressed as the mean ± SEM. *P < 0.05 for diabetic vs. control; #P < 0.05 for diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ vs. control.
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determined using a protein assay kit (Bio-Rad, Hercules,
CA). Equal amounts of each whole-cell protein lysate
(50 μg) were mixed with reducing sample buffer (0.92 M
Tris-HCl [pH 8.8], 1.5% SDS, 4% glycerol and 280 mM
2-mercaptoethanol) and separated by discontinuous
SDS-PAGE. The proteins were then transferred onto
nitrocellulose membranes using a Bio-Rad Trans-Blot
electrophoretic transfer device. Next, the membranes were
blocked for 1 h at room temperature with 1% BSA or 5%
skim milk dissolved in TBS (20 mM Tris-HCl [pH 7.4] and
150 mM NaCl) supplemented with 0.1% Tween 20 and
then incubated in the same blocking buffer with an anti-
phospho-PKB/AKT (S473) or pan-AKT antibody (1:5,000;
Cell Signaling). The blots were thoroughly rinsed and thenTable 2 Significant alterations in body weight, insulin level, l
at 8 weeks of age
Parameters Offspring of control dams
At bir
Body weight (g) 1.24 ± 0.1
At age of 8
body weight (g) 20 ± 1.9
Blood glucose (mg/dl) 141 ± 12
Insulin (ng/ml) 2.4 ± 0.1
WBCs count (103/ul) 15 ± 0.9
Lymphocytes (%) 75 ± 5.8
Monocytes (%) 5 ± 0.18
Neutrophils (%) 20 ± 1.45
ROS (nmol/ml) 11 ± 1.9
Hydroperoxide (mg/100 ml) 17 ± 2.7
The results are expressed as the mean ± SEM. *P < 0.05 for diabetic vs. control; #P <incubated with an HRP-labeled species-matched secondary
antibody for 1 h. Protein bands were detected by enhanced
chemiluminescence (ECL, SuperSignal West Pico Chemilu-
minescent Substrate, Perbio, Bezons, France), and the ECL
signals were recorded on Hyperfilm ECL. To quantify the
protein band intensities, the films were scanned, saved as
TIFF files, and analyzed using NIH ImageJ software.
Statistical analysis
The data were tested for normality using the Anderson-
Darling test and for homogeneity variances prior to
further statistical analysis. The data were normally dis-
tributed and are expressed as the mean ± standard error
of the mean (SEM). Significant differences among groups
were analyzed by one- or two-way ANOVA followed byymphocyte counts, and levels of free radicals in offspring
Offspring of diabetic dams Offspring of diabetic damssupplemented with TQ
th
1.89 ± 0.1* 1.39 ± 0.11#
weeks
28.9 ± 2.9* 23.3 ± 2.3
218 ± 19.5* 178.5 ± 13.4#+
1.52 ± 0.15* 2.1 ± 0.19#
11 ± 0.1* 13.5 ± 0.18#
58 ± 4.8* 71.6 ± 0.18#
4 ± 0.35 5 ± 0.6
19 ± 1.3 21 ± 1.95
25 ± 3.9* 17 ± 2.1#+
34 ± 4.4* 24 ± 2.8#+
0.05 for diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ vs. control.
Figure 1 TQ restores the lipid profile in the offspring of diabetic dams. The levels of HDL-C (A), LDL-C (B), cholesterol (C), and MDA (D)
were determined in offspring (8 weeks old) born to control dams (CD; black bars), diabetic dams (DD; gray bars), and diabetic dams
supplemented with TQ (DD + TQ; hatched bars) as described in the Materials and Methods section. The accumulated data from 10 individual
mice from each group are expressed as the mean level of each lipid ± SEM. *P < 0.05 for diabetic vs. control; #P < 0.05 for diabetic + TQ vs.
diabetic; +P < 0.05 for diabetic + TQ vs. control.
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statistical software (GraphPad Software). The data were
also reanalyzed by one- or two-way ANOVA followed by
Tukey’s posttest using SPSS software (version 17). Differ-
ences were considered statistically significant at P <
0.05. *P < 0.05 for diabetic vs. control; #P < 0.05 for
diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ
vs. control.
Results
Characteristics of gestational diabetes and its
complications in offspring
The treatment of pregnant mice with STZ resulted in
marked hyperglycemia that was still detectable during
lactation. The success rate of pregnancy among the
dams was clearly decreased by the induction of diabetes
(Table 1). The induction of gestational diabetes (GD)
before mating was associated with a decreased number
of delivered neonates (64 pups born to DD vs. 121 pupsborn to CD) (Table 1). Treatment of DD with TQ during
pregnancy and lactation had a clear effect on the total
number of delivered neonates (96 pups vs. 64 in DD that
were not treated with TQ). Furthermore, at 4 weeks of age,
many of the pups born to DD that had been treated with
TQ were still alive (85 pups vs. 48 pups born to DD that
were not treated with TQ vs. 115 pups born to CD)
(Table 1). Offspring born to DD typically presented higher
body weights (macrosomic neonates) at birth compared to
neonates born to DD treated with TQ and those born to
CD. At 8 weeks of age, although the percentage of mortality
was high among the pups born to DD (Table 2), these pups
sustained a significantly higher body weight compared to
pups born to DD treated with TQ and those born to CD.
Moreover, at 8 weeks of age, the blood glucose and free
radical levels (ROS and hydroperoxide) were significantly
higher in the plasma of pups born to DD compared to pups
born to DD treated with TQ and those born to CD. By con-
trast, offspring born to DD exhibited a significant reduction
Figure 2 TQ restores plasma cytokine levels in the offspring of
diabetic dams. The levels of plasma cytokines were measured in
freshly isolated blood from offspring (8 weeks old) born to CD (black
bars), DD (gray bars), and DD+ TQ (hatched bars) as described in the
Materials and Methods section. The accumulated data from 10 individual
male mice from each group are expressed as the mean level of each
cytokine (pg/ml) ± SEM. *P < 0.05 for diabetic vs. control; #P < 0.05 for
diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ vs. control.
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in insulin levels compared to offspring born to DD treated
with TQ and those born to CD (Table 2).
Offspring born to DD exhibits elevation in the lipid
profiles with a tendency for abnormal obesity
We previously observed that offspring born to DD typi-
cally presented higher body weights (macrosomic
neonates) at birth and sustained a significantly higher
body weight at 8 weeks of age compared to pups born to
DD treated with TQ and those born to CD (Table 2). We
therefore monitored the lipid profiles of the offspring
of the 3 groups at 8 weeks of age. The levels of
HDL-C (Figure 1A), LDL-C (Figure 1B), and cholesterol
(Figure 1C) were significantly higher in the plasma of pups
born to DD compared to pups born to DD treated with
TQ and those born to CD. Moreover, MDA is a marker of
oxidative lipid damage and a major oxidative product of
peroxidized polyunsaturated fatty acids. The level of MDA
was significantly increased in the plasma of pups born to
DD compared to pups born to DD treated with TQ and
those born to CD (Figure 1D). Supplementation of DD
with TQ during pregnancy and lactation obviously restored
the plasma lipid profiles of their offspring compared to
those born to DD that were not treated with TQ.
Supplementation of DD with TQ during GD restores the
plasma cytokine profiles in their offspring
Cytokines are secreted by specific cells of the immune
system, carry signals locally between cells, and are
critical for the development and function of both the
innate and adaptive immune responses. Plasma cytokine
levels of the pro-inflammatory cytokines IL-1β, IL-6 and
TNF-α, the T cell growth factor IL-2, and the B-cell
stimulatory factor-1 IL-4 were evaluated in the offspring
at 8 weeks of age. The levels of the pro-inflammatory
cytokines IL-1, IL-6, and TNF-α were significantly ele-
vated in the offspring of DD compared to the offspring
of CD (Figure 2). Nevertheless, treatment of DD with
TQ during pregnancy and lactation significantly restored
the levels of IL-1β, IL-6, and TNF-α in their offspring
compared to those born to DD that were not treated
with TQ. By contrast, the plasma levels of IL-2 (a T cell
growth factor required for the survival and proliferation
of T cells) and IL-4 (a cytokine secreted by activated
T cells that induces the activation and differentiation
of B cells) were significantly reduced in the offspring of
DD compared to those of CD and DD treated with TQ.
Treatment of DD with TQ during GD enhances SEB-
mediated lymphocyte proliferation in their offspring
Because decreased levels of IL-2 and IL-4 could induce a
reduction in lymphocyte proliferation, we examined
whether the lymphocytes of the offspring exhibited anexhausted status after superantigen stimulation using a
CFSE dilution assay. PBMCs were isolated from offspring
of CD, DD, and DD treated with TQ. The cells were then
labeled with CFSE, stimulated with SEB, cultured for 6 days,
and analyzed by flow cytometry. The plots were gated on
lymphocytes according to the forward and side scatter and
then on viable cells to exclude dead cells. The percentages
of CFSE-lo (proliferating cells) and CFSE-high (non-proli-
ferating cells) within the lymphocyte population are
presented as dot plots (Figure 3). In one representative
experiment, we determined that the percentage of lympho-
cyte proliferation was markedly increased from 0.2% in
medium-treated cells to 75% in SEB-treated cells in the
offspring of CD (Figures 3A & 3B). The offspring of DD
exhibited a marked reduction (24%) in the proliferative
capacity of their lymphocytes (Figure 3C), and the percen-
tage of proliferating lymphocytes was markedly restored
(54%) in the offspring born to DD that were treated
with TQ (Figure 3D). Accumulated data from 10
separate experiments with 10 offspring in each group
revealed that the percentage of proliferating lymphocytes
was significantly reduced from 73 ± 7% in the offspring of
CD to 29 ± 5% in the offspring of DD (Figure 3E). Interes-
tingly, the percentage of proliferating lymphocytes was
significantly restored to 56 ± 6.4% in the offspring of DD
that were treated with TQ.
Treatment of DD with TQ during GD restores the
impaired PI3K/AKT signaling pathway in the lymphocytes
of their offspring
We investigated whether impaired lymphocyte proliferation
in the offspring of DD is associated with aberrant
Figure 3 TQ supplementation restores lymphocyte proliferation upon antigen stimulation. PBMCs were isolated from the blood of
offspring (8 weeks old) born to CD, DD, and DD + TQ, and their proliferative capacity was assessed in response to SEB following 6 days of
stimulation using CFSE dilution assays and flow cytometry analysis. The plots were gated on unstimulated (A) or SEB-stimulated lymphocytes (B)
of offspring born to CD, SEB-stimulated lymphocytes of offspring born to DD (C), and SEB-stimulated lymphocytes of offspring born to DD (D)
and were then gated on viable cells to exclude dead cells. The numbers on the left side represent the percentage of CFSE-lo (proliferating cells)
within the cell population. One representative experiment is shown. (E) The data obtained for offspring (n = 10) born to CD (black bars), DD (gray
bars), and DD + TQ (hatched bars) are expressed as the mean percentages of proliferating lymphocytes ± SEM. *P < 0.05 for diabetic vs. control;
#P < 0.05 for diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ vs. control.
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offspring of CD, DD, and DD treated with TQ, followed by
pretreatment with medium, WM, and SH5 for 1 h before
stimulation with or without CXCL12 (250 ng/ml) for
5 min. In one representative experiment, CXCL12 induced
an obvious phosphorylation of AKT in the PBMCs from
the offspring of CD. The PBMCs of the offspring of DD
exhibited aberrant phosphorylation of AKT following
stimulation with CXCL12. However, the CXCL12-mediated
phosphorylation of AKT was clearly restored in the PBMCs
of the offspring of DD that were treated with TQ during
gestation and lactation. The treatment of PBMCs with WM
and SH5 prior to stimulation with CXCL12 markedly
inhibited AKT phosphorylation, as shown for the PBMCs
from the offspring of DD (Figure 4A). This experiment was
conducted with 5 offspring from each group, and the results
are expressed as the mean ± SEM of the normalized phos-
phorylation values (Figure 4B). The level of phosphorylatedAKT was normalized to the amount of total AKT. We
observed that the CXCL12-mediated phosphorylation of
AKT was significantly diminished from 380 ± 31 in the
PBMCs from the offspring of CD to 150 ± 13 in the PBMCs
from the offspring of DD. Moreover, CXCL12-induced
AKT phosphorylation was restored (320 ± 24) in the
PBMCs from the offspring of DD treated with TQ.
Discussion
Diabetes mellitus is associated with many metabolic com-
plications [25]. As a result of these complications, in this
study, the pregnancy success rate among the dams was
clearly decreased, and significantly fewer neonates were
born to diabetic mice compared with control rats. In
addition, GD resulted in macrosomic pups with several
postpartum complications. For example, at 8 weeks of age,
blood glucose and free radical levels (ROS and hydroper-
oxide) were significantly higher in the plasma of pups born
Figure 4 PI3K/AKT signaling is impaired in the offspring of DD.
The level of phosphorylated AKT (p-AKT), which is part of the main
signaling pathway downstream of PI3K, was determined by western
blot analysis of PBMCs after stimulation with CXCL12. PBMCs were
isolated from the offspring of CD, DD, and DD + TQ and pretreated
with medium, WM, and SH5 for 1 h before stimulation with medium
(0) or CXCL12 (250 ng/ml) for 5 min. In one representative experiment
(A), the phosphorylation of AKT was monitored using an anti-p-AKT
antibody and normalized against the total relevant protein (pan-AKT) on
stripped blots. The experiment was conducted for 5 offspring from each
group, and the results are expressed as the mean ± SEM normalized
phosphorylation values (B). *P < 0.05 for diabetic vs. control; #P < 0.05
for diabetic + TQ vs. diabetic; +P < 0.05 for diabetic + TQ vs. control.
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from the generation of free radicals, which damage cellular
components such as lipids, proteins, and DNA [26,27].
ROS were elevated in STZ-induced diabetic mice in the
present study, as previously demonstrated by Kojo et al.
[28]. The number of circulating lymphocytes and insulin
levels significantly decreased in pups born to DD com-
pared to offspring born to DD treated with TQ and those
born to CD. Furthermore, offspring born to DD exhibited
increased lipid levels and were abnormally obese. Interes-
tingly, supplementation of DD with TQ during pregnancy
and lactation significantly restored the plasma lipid pro-
files of their offspring. Increases in blood glucose and
plasma fat levels are risk factors for metabolic syndrome
and its future complications, such as vascular disease [29].
The modifications induced by maternal diabetes may be
attributed to hyperglycemia and fetal hyperinsulinemia,
which affect lipid and protein synthesis [30]. Furthermore,
maternal hyperglycemia stimulates fetal growth due to
the increased availability of glucose in the blood and
inappropriate regulation of growth factors, resulting in
macrosomic pups [31]. TQ is a promising bioactive phyto-
chemical compound which is found in the seeds of Nigella
sativa plant. It has recently attracted significant scientific
attention due to its potent in vitro and in vivo anticancer,
anti-inflammatory and effective antioxidant properties for
normal cells. TQ is well known for scientists where there
are more than 400 published works concluding its proper-
ties and effects on many different cells including normal
and cancer cells. TQ is easily absorbed from the intestine
to the blood and then to all the body organs triggering
different effects on all the body organs [32]. Because it
possesses potent antioxidant properties, supplementation
with TQ improves the risk of developing diabetic compli-
cations, such as decreasing elevated levels of ROS and
MDA (marker of oxidative lipid damage) and regulating
plasma concentrations of cholesterol, triglycerides, and
glucose [19]. Once it is absorbed from the intestine to the
blood, TQ triggers multiple signaling pathways on differ-
ent organs. We recently demonstrated that TQ amelio-
rates the immunological and histological changes induced
by exposure to imidacloprid insecticide [33]. Our present
data demonstrated that TQ ameliorated the aberrant
hydroperoxide and ROS levels in pups born to DD. The
results indicated a subsequent decrease in the percentage
of abortions, an increase in the number of successful preg-
nancies, and decreased pup mortality. These phenomena
may also be mediated by increases in the levels of GST,
GSH, and catalase and a decrease in the DNA damage
caused by TQ [34]. The results of this work indicate that
the use of TQ can be beneficial in preventing and treating
hyperglycemia and dyslipidemias in the offspring of dia-
betic dams. The hypoglycemic effect of TQ in diabetic rats
is mediated through a decrease in hepatic gluconeogenesis
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levels, and this effect has been attributed to the antioxi-
dant activity of TQ, which may alleviate the damage to
beta cells in the pancreas caused by STZ [32]. The findings
of the current study are consistent with the findings of our
previous study that the nutritional supplementation of GD
mothers with the natural antioxidant TQ during pregnancy
and lactation improves the risk of developing diabetic com-
plications [17]. In the present study, the levels of the
pro-inflammatory cytokines IL-1β, IL-6, and TNF-α were
significantly elevated in the offspring of DD and were
restored by TQ treatment. Similar observations were made
in our previous study [17], in which supplementation with
TQ was found to have broad anti-inflammatory effects in a
diabetic rat model. These results are in agreement with pre-
vious studies [36,37], in which TQ was shown to attenuate
the levels of pro-inflammatory cytokines. In offspring born
to DD, the plasma levels of IL-2 and IL-4 are significantly
reduced, providing important evidence of impaired
immune function [38]. By contrast, a previous study has
revealed that serum IL-4 levels did not vary among gesta-
tional diabetic mothers and control mothers or macrosomic
babies and control babies [13]. In pups born to DD, we ob-
served a marked decrease in the plasma levels of IL-2 and
IL-4, accompanied by a marked reduction in the prolifera-
tive capacity of antigen-stimulated lymphocytes. Several
studies have revealed that decreased plasma levels of IL-2,
which promotes Tcell survival and proliferation, occur con-
sistently in several diseases and indicate defective T cell
function. In this study, we found that TQ significantly re-
stored both the levels of IL-2 and IL-4 and lymphocyte pro-
liferation. This restorative effect of TQ improved and
maintained an efficient immune response of lymphocytes
in the offspring, in agreement with our previous work [17].
We previously demonstrated that vitamin C, as an antioxi-
dant agent, reconstitutes polyfunctional T cells and amelio-
rates diabetic complications in streptozotocin-induced
diabetic rats [24]. Furthermore, other investigators demon-
strated that combined treatment with vitamin E and
vitamin C decreases oxidative stress and improves fetal out-
come in experimental diabetic pregnancy [39]. Thus, to
compare the effects of TQ with another antioxidant further
studies of combinations of TQ and vitamin C during GD
are underway. Increased AKT pathway signaling has been
shown to be directly correlated with increased rates of glu-
cose metabolism [40]. The PI3K/AKT signaling pathway is
important for insulin signaling and glucose metabolism,
lymphocyte migration, proliferation, and differentiation,
and TGF-β signaling regulation, making it an important
therapeutic target for the treatment of cancer, diabetes, and
other diseases [41]. Our data demonstrates that the supple-
mentation of DD with TQ during GD restores the impaired
PI3K/AKT signaling pathway in the lymphocytes of their
offspring. Regulation of the PI3K/AKT signaling pathwayby TQ may improve the risk of developing diabetic compli-
cations via insulin signaling and glucose metabolism.
Although TQ has a wide range of therapeutic benefits,
there is lack of clinical evaluation of TQ in humans and the
need for clinical studies to assess its health benefits on
human is required. Therefore, toxicity studies are essential
and a step to the right direction to provide a solid starting
point for further preclinical and clinical evaluation of such
an important phytochemical compound. We previously
explored the effects of TQ on human cancer cells, as well
as in mice and rat models [17,42,43]. Before we started to
used the TQ in our laboratory, we determined the max-
imum tolerated dose of TQ for intraperitoneal injection
and oral gavages. We found that the maximum tolerated
dose was 20 mg/kg in male and 15 mg/kg in female rodent,
whereas for oral administration it was 150 mg/kg in both
male and female rats. Therefore, we used a low dose of TQ
that has no toxicity effects even it administered for up to
3 months. In the present study, a low dose of TQ
(20 mg/kg body weight/day) was administered during
gestation and lactation periods. Taken together, our
data suggest that the use of TQ is a potential strategy
for the prevention of DM, abnormal lipid profiles and
their complications, and to treat these diseases by
preventing the development of diabetic complications and
maintaining an efficient lymphocyte immune response in
offspring later in life.
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